Artelo Biosciences, Inc. announced that it will receive $20,096,972 in funding on May 13, 2022. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 USD | +8.45% | +18.46% | +10.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.00% | 4.58M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- ARTL Stock
- News Artelo Biosciences, Inc.
- Artelo Biosciences, Inc. announced a financing transaction